Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 5087

1.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
[PubMed - indexed for MEDLINE]
2.

Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?

Bukowska H, Stanosz S, Zochowska E, Millo B, Sieja K, Chełstowski K, Naruszewicz M.

Metabolism. 2005 Jan;54(1):72-8.

PMID:
15562383
[PubMed - indexed for MEDLINE]
3.

[Biochemical aspects of modified, transdermal replacement hormone therapy].

Stanosz S, Zochowska E, Stanosz M.

Ginekol Pol. 2007 Dec;78(12):922-8. Polish.

PMID:
18411913
[PubMed - indexed for MEDLINE]
4.
5.

Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.

Peichl P, Griesmacher A, Müller MM, Marteau R, Kumpan W, Bröll H.

Gynecol Endocrinol. 2000 Oct;14(5):374-81.

PMID:
11109977
[PubMed - indexed for MEDLINE]
6.

Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.

Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.

J Endocrinol Invest. 1992 Jul-Aug;15(7):533-8.

PMID:
1280287
[PubMed - indexed for MEDLINE]
8.

Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.

Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.

Clin Endocrinol (Oxf). 1999 Jun;50(6):791-800.

PMID:
10468952
[PubMed - indexed for MEDLINE]
9.

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.

Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.

J Bone Miner Res. 2002 Oct;17(10):1904-12.

PMID:
12369794
[PubMed - indexed for MEDLINE]
10.

Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.

Tiraş MB, Noyan V, Yildiz A, Biberoğlu K.

Climacteric. 2000 Jun;3(2):92-101.

PMID:
11910657
[PubMed - indexed for MEDLINE]
11.

Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.

Suvanto-Luukkonen E, Sundström H, Penttinen J, Kauppila A.

Arch Gynecol Obstet. 1998;261(4):201-8.

PMID:
9789651
[PubMed - indexed for MEDLINE]
12.
13.

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.

Dane C, Dane B, Cetin A, Erginbas M.

Gynecol Endocrinol. 2007 Jul;23(7):398-403.

PMID:
17701771
[PubMed - indexed for MEDLINE]
14.

Oral 17beta-estradiol and sequential progesterone in menopause: effects on insulin-like growth factors and their binding proteins.

Mozzanega B, Babbo GL, Salmaso L, De Toni R, Schiavo A, Mioni R, de Kreutzenberg SV.

Gynecol Endocrinol. 2007 Jan;23(1):50-7.

PMID:
17484513
[PubMed - indexed for MEDLINE]
15.

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

JAMA. 2002 May 22-29;287(20):2668-76.

PMID:
12020302
[PubMed - indexed for MEDLINE]
16.

Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.

Rota F, Savanelli MC, Tauchmanova L, Savastano S, Lombardi G, Colao A, Di Somma C.

J Endocrinol Invest. 2008 Feb;31(2):94-102.

PMID:
18362499
[PubMed - indexed for MEDLINE]
17.

[Effects on bone mass of oral alendronate, hormone replacement therapy and combined regimes in post-menopausal women: preliminary report on a comparative study].

Ulla MR, Araujo GL, Giglione F, Fajreldines F, Domingo P, Noriega R, Rivoira MA.

Medicina (B Aires). 1997;57 Suppl 1:49-55. Spanish.

PMID:
9567355
[PubMed - indexed for MEDLINE]
18.

Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.

Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.

J Endocrinol Invest. 1996 Sep;19(8):535-41.

PMID:
8905477
[PubMed - indexed for MEDLINE]
19.

The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.

O'Sullivan AJ, Crampton LJ, Freund J, Ho KK.

J Clin Invest. 1998 Sep 1;102(5):1035-40.

PMID:
9727072
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk